Sheyu Zhang

发表

TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer

Xiaojia Wang, Zi-Zhou Zhang, Qiusheng Guo, 2021, Frontiers in Cell and Developmental Biology.

Targeting TAF1 with BAY-299 induces antitumor immunity in triple-negative breast cancer.

Qin Wu, Wenjun Chen, Xueying Liu, 2023, Biochemical and biophysical research communications.

Type‐I protein arginine methyltransferase inhibition primes anti‐programmed cell death protein 1 immunotherapy in triple‐negative breast cancer

Sheyu Zhang, Yong Wei, Xiaojia Wang, 2023, Cancer.